These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800 [TBL] [Abstract][Full Text] [Related]
3. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
4. Number of patients potentially eligible for proton therapy. Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591 [TBL] [Abstract][Full Text] [Related]
5. Proton beam radiation therapy in the treatment of pediatric central nervous system malignancies: a review of the literature. Semenova J J Pediatr Oncol Nurs; 2009; 26(3):142-9. PubMed ID: 19460891 [TBL] [Abstract][Full Text] [Related]
6. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Palm A; Johansson KA Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313 [TBL] [Abstract][Full Text] [Related]
7. Technology insight: Proton beam radiotherapy for treatment in pediatric brain tumors. Yock TI; Tarbell NJ Nat Clin Pract Oncol; 2004 Dec; 1(2):97-103; quiz 1 p following 111. PubMed ID: 16264827 [TBL] [Abstract][Full Text] [Related]
8. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401 [TBL] [Abstract][Full Text] [Related]
14. Secondary neutrons in clinical proton radiotherapy: a charged issue. Brenner DJ; Hall EJ Radiother Oncol; 2008 Feb; 86(2):165-70. PubMed ID: 18192046 [TBL] [Abstract][Full Text] [Related]
15. The potential role of proton beams in radiation oncology. Loeffler JS; Smith AR; Suit HD Semin Oncol; 1997 Dec; 24(6):686-95. PubMed ID: 9422264 [TBL] [Abstract][Full Text] [Related]
16. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Weber DC; Trofimov AV; Delaney TF; Bortfeld T Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341 [TBL] [Abstract][Full Text] [Related]
17. The clinical experience with particle therapy in adults. Schulz-Ertner D Cancer J; 2009; 15(4):306-11. PubMed ID: 19672147 [TBL] [Abstract][Full Text] [Related]
18. Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique. Cochran DM; Yock TI; Adams JA; Tarbell NJ Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1336-42. PubMed ID: 18029111 [TBL] [Abstract][Full Text] [Related]
19. Current status of radiotherapy with proton and light ion beams. Greco C; Wolden S Cancer; 2007 Apr; 109(7):1227-38. PubMed ID: 17326046 [TBL] [Abstract][Full Text] [Related]
20. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Mock U; Bogner J; Georg D; Auberger T; Pötter R Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]